Physician profile
Norland Ng
NPI 1063537041
$132,187.75
in general payments reported to CMS, 2019-2025
100 companies · $46K in 2025
The $46K reported for 2025 was more than what 96% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $10K · 2021: $15K · 2022: $15K · 2023: $13K · 2024: $14K · 2025: $46K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $32K · Food and Beverage: $28K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,345 · Travel and Lodging: $3,035 · Long Term Medical Supply Or Device Loan: $1,280 · Education: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $32,015.00 |
| Food and Beverage | $28,337.54 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,345.00 |
| Travel and Lodging | $3,035.32 |
| Long Term Medical Supply Or Device Loan | $1,279.73 |
| Education | $585.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agios Pharmaceuticals, INC. | $24,062.29 | 2024-2025 | Pyrukynd |
| Astrazeneca Pharmaceuticals LP | $12,564.71 | 2019-2025 | Tagrisso, Imfinzi, Enhertu |
| Boehringer Ingelheim Pharmaceuticals, INC. | $10,486.48 | 2019-2025 | Gilotrif, Jardiance |
| Janssen Biotech, INC. | $5,706.86 | 2019-2025 | Rybrevant, Darzalex, Erleada |
| E.R. Squibb & Sons, L.L.C. | $5,393.21 | 2019-2025 | Opdivo, Opdualag, Eliquis |
| Exelixis INC. | $4,873.56 | 2019-2025 | Cabometyx |
| Novartis Pharmaceuticals Corporation | $4,426.65 | 2019-2025 | Promacta |
| Pfizer INC. | $4,233.25 | 2019-2025 | |
| Genzyme Corporation | $3,968.59 | 2019-2025 | |
| Dova Pharmaceuticals | $3,592.27 | 2019-2021 | |
| Emd Serono, INC. | $3,197.00 | 2019-2025 | Tepmetko, Bavencio |
| Incyte Corporation | $2,768.45 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Janssen Scientific Affairs, LLC | $2,692.39 | 2022-2025 | Rybrevant |
| Daiichi Sankyo INC. | $2,583.18 | 2020-2025 | Enhertu, Datroway, Injectafer |
| Abbvie INC. | $2,562.36 | 2019-2025 |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,326.72 | 2019-2025 | Evenity, Uplizna, Prolia |
| Taiho Oncology, INC. | $2,269.93 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $2,018.41 | 2019-2025 | Fruzaqla, Ninlaro, Alunbrig |
| Merck Sharp & Dohme LLC | $1,790.89 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Lilly USA, LLC | $1,578.39 | 2019-2025 | Jaypirca, Verzenio, Jardiance |
| Rigel Pharmaceuticals, INC. | $1,506.36 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Puma Biotechnology, INC. | $1,487.03 | 2019-2022 | |
| Recordati_rare_diseases_inc. | $1,480.06 | 2023-2025 | Enjaymo, Sylvant |
| Glaxosmithkline, LLC. | $1,476.36 | 2019-2025 | Jemperli, Zejula, Ojjaara |
| Novo Nordisk INC | $1,323.84 | 2020-2025 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $1,277.68 | 2019-2025 | |
| Eisai INC. | $1,194.52 | 2019-2025 | |
| Gilead Sciences, INC. | $1,139.49 | 2019-2025 | Trodelvy |
| Seagen INC. | $1,130.60 | 2019-2023 | Padcev, Tukysa, Adcetris |
| Celgene Corporation | $1,115.37 | 2019-2025 | Reblozyl, Pomalyst |
| Astellas Pharma US INC | $833.93 | 2019-2025 | Xtandi, Xospata, Vyloy |
| Genentech USA, INC. | $821.49 | 2019-2025 | Tecentriq, Phesgo |
| Alexion Pharmaceuticals, INC. | $746.18 | 2019-2025 | Ultomiris |
| Jazz Pharmaceuticals INC. | $691.37 | 2019-2025 | |
| Sobi, INC | $640.51 | 2022-2025 | |
| Horizon Therapeutics Plc | $509.04 | 2019-2023 | Krystexxa |
| Stemline Therapeutics INC. | $503.90 | 2022-2025 | Orserdu, Elzonris |
| Sumitomo Pharma America, INC. | $499.17 | 2023-2025 | Orgovyx, Gemtesa |
| Array Biopharma INC | $485.82 | 2020-2025 | Braftovi, Mektovi, Lorbrena |
| Mirati Therapeutics, INC. | $467.35 | 2023-2024 | Krazati |
| Regeneron Healthcare Solutions, INC. | $436.11 | 2019-2025 | Libtayo |
| Beone Medicines USA, INC. | $434.58 | 2025 | Tevimbra, Brukinsa |
| Beigene USA, INC. | $418.55 | 2020-2025 | Brukinsa, Tevimbra |
| Myovant Sciences INC. | $394.60 | 2021-2022 | |
| Deciphera Pharmaceuticals INC. | $382.89 | 2021-2025 | Qinlock, Romvimza, Tgct |
| Foundation Medicine, INC. | $378.75 | 2020-2023 | |
| Amarin Pharma, INC. | $337.76 | 2019-2023 | |
| Acrotech Biopharma INC. | $318.97 | 2021-2025 | Beleodaq |
| Aveo Pharmaceuticals, INC. | $311.15 | 2022-2025 | |
| Nestle Healthcare Nutrition INC. | $300.18 | 2020-2023 | |
| Kite Pharma, INC. | $298.13 | 2020-2023 | |
| Kowa Pharmaceuticals America, INC. | $293.27 | 2019-2024 | Livalo, Seglentis, Zoryve |
| Janssen Pharmaceuticals, INC | $270.38 | 2019-2021 | |
| Opko Pharmaceuticals, LLC | $238.83 | 2019-2022 | |
| Pharmacyclics LLC, An Abbvie Company | $226.77 | 2019-2023 | Imbruvica |
| Tersera Therapeutics LLC | $219.16 | 2021-2025 | Zoladex, Xermelo |
| Clovis Oncology, INC. | $218.30 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $213.57 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $197.00 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $191.39 | 2021-2024 | Myrisk |
| Karyopharm Therapeutics INC. | $182.71 | 2024-2025 | Xpovio |
| Medtronic, INC. | $178.45 | 2025 | Symplicity G3 |
| Aimmune Therapeutics, INC. | $145.66 | 2024-2025 | Zenpep |
| Exact Sciences Corporation | $140.54 | 2024-2025 | Cologuard Collection Kit |
| Ipsen Biopharmaceuticals, INC | $128.69 | 2019-2025 | Tazverik, Onivyde, Somatuline Depot |
| Novocure INC. | $128.52 | 2020-2025 | Optune Lua (Novottf-200t), Optune Lua (Novottf-200t) |
| Tesaro, INC. | $128.08 | 2019 | |
| Tempus Ai, INC | $121.96 | 2024 | Xt Cdx |
| Verastem, INC. | $119.66 | 2019-2020 | |
| Allergan, INC. | $116.63 | 2019-2020 | |
| Akebia Therapeutics INC | $109.70 | 2019-2022 | |
| Kyowa Kirin, INC. | $101.00 | 2019 | |
| Intra-Sana Laboratories | $100.00 | 2022 | |
| Blueprint Medicines Corporation | $99.84 | 2020-2021 | |
| Ibsa Pharma INC. | $93.71 | 2021 | |
| Springworks Therapeutics, INC. | $85.83 | 2024-2025 | Gomekli, Ogsiveo |
| Shield Therapeutics INC | $85.02 | 2024-2025 | |
| Eusa Pharma (US) LLC | $84.44 | 2021-2022 | |
| Genmab U.S., INC. | $79.90 | 2023-2024 | Epkinly |
| Teva Pharmaceuticals USA, INC. | $79.73 | 2019-2020 | |
| Servier Pharmaceuticals LLC | $79.16 | 2021-2025 | |
| Adc Therapeutics America, INC. | $75.61 | 2024-2025 | |
| Verity Pharmaceuticals INC. | $73.13 | 2021-2024 | Trelstar |
| Coherus Oncology, INC. | $67.78 | 2022 | |
| Advanced Accelerator Applications | $65.21 | 2020 | |
| Accord Healthcare, INC. | $62.50 | 2025 | |
| Acceleron Pharma, INC. | $60.82 | 2020 | |
| Azurity Pharmaceuticals, INC. | $60.82 | 2025 | Danziten |
| Epizyme, INC. | $54.88 | 2020-2022 | |
| Shionogi INC | $51.00 | 2019 | |
| Insmed, INC. | $50.00 | 2025 | Brinsupri, Arikayce |
| Pharmaessentia USA Corporation | $48.40 | 2022-2023 | Besremi |
| Secura Bio, INC. | $46.18 | 2024 | Copiktra |
| Invivyd INC | $46.17 | 2025 | Pemgarda |
| Vifor Pharma, INC. | $37.78 | 2020-2021 | |
| Sanofi Pasteur INC. | $37.10 | 2019-2020 | |
| Caris Mpi, INC. | $36.36 | 2025 | Mi Cancer Seek |
| Chiesi USA, INC. | $29.99 | 2024 | Mycapssa |
| Seqirus USA INC | $28.99 | 2023-2024 | Flucelvax, Flucelvax Quadrivalent |
| Arbor Pharmaceuticals, INC. | $28.47 | 2020 |
Drugs and devices associated with these payments
Pyrukynd $24KCabometyx $3,375Tagrisso $2,769Rybrevant $2,764Lonsurf $1,983Enhertu $1,976Talzenna $1,858Kisqali $1,761Enjaymo $1,679Imfinzi $1,375Tavalisse $876Rezlidhia $799Xtandi $669Opdivo $612Keytruda $611Rybelsus $544Ozempic $517Nubeqa $507Orgovyx $487Darzalex $473Krazati $467Stivarga $441Vitrakvi $441Orserdu $433Zepzelca $421Lenvima $416Jaypirca $404Jakafi $385Tukysa $382Fruzaqla $377Reblozyl $376Ninlaro $375Erleada $373Tevimbra $362Monjuvi $360Verzenio $358Fabhalta $350Brukinsa $343Tecentriq $341Imbruvica $337Gavreto $328Inlyta $318Padcev $309Vonjo $303Epkinly $301Creon $297Lorbrena $295Fotivda $285Qinlock $283Beleodaq $281Evenity $275Scemblix $270Sarclisa $266Braftovi $264Uplizna $264Talvey $260Ibrance $259Prolia $254Mektovi $248Gemtesa $246Libtayo $245Jardiance $219Ultomiris $217Elrexfio $204Breztri $202Zenpep $199Doptelet $197Balversa $196Tecvayli $194Comirnaty $189Linzess $186Wayrilz $185Inqovi $183Xpovio $183Retevmo $183Carvykti $182Symplicity G3 $178Pomalyst $177Lynparza $175Tepmetko $167Xofigo $166Piqray $165Pemazyre $159Trodelvy $156Zoladex $150Akeega $148Adcetris $144Vectibix $142Nplate $142Xgeva $142Lutathera $141Cologuard Collection Kit $141Myrisk $137Gilotrif $135Datroway $135Bosulif $131Bavencio $128Sylvant $124Zejula $119Jemperli $119
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norland Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.